Clinical trial
Randomized Pilot Trial to Evaluate the Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus (PENCIL)
NCT06356740 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Pilot Trial to Evaluate the Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus (PENCIL)
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- September 1, 2024
- Completion date
- June 1, 2029
- Enrollment
- 70 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
systemic lupus erythematosus